Rodman & Renshaw analyst Elemer Piros is grim about the prospects for obesity drugs over all, noting to the Wall Street Journal that the FDA wants a side effect profile on these drugs that is equivalent to diet and exercise. The bottom line: “This whole space is pretty much dead.”

Analysts take on obesity drugs turns grim after lorcaserin CRL – FierceBiotech

Obesity appears to be associated with increased assisted reproductive technology cycle cancellation and treatment and pregnancy failures, and also with oocyte immaturity in women undergoing in vitro fertilization, according to two studies presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 23 to 27 in Denver.

ASRM: Relationship Between Obesity and Infertility Explored –Doctors Lounge